Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 0 | 0 | 0 | 0 | 31 |
| Gross Profit | N/A | N/A | N/A | 0 | 31 |
| Operating Expenses | 24,622 | 26,731 | 22,512 | 20,790 | 23,525 |
| Operating Income | -24,622 | -26,731 | -22,512 | -20,790 | -23,494 |
| Interest Expense | 1,463 | 1,710 | 1,699 | 1,639 | 1,641 |
| Other Income | 90 | 5,735 | -12,758 | 18,709 | -146 |
| Pre-tax Income | -25,995 | -22,706 | -36,969 | -3,720 | -25,281 |
| Net Income Continuous | -25,995 | -22,706 | -36,969 | -3,720 | -25,281 |
| Net Income | $-25,995 | $-22,706 | $-36,969 | $-3,720 | $-25,281 |
| EPS Basic Total Ops | -0.25 | -0.22 | -0.36 | -0.04 | -0.25 |
| EPS Basic Continuous Ops | -0.25 | -0.22 | -0.36 | -0.04 | -0.25 |
| EPS Diluted Total Ops | -0.25 | -0.22 | -0.36 | -0.03 | -0.25 |
| EPS Diluted Continuous Ops | -0.25 | -0.22 | -0.36 | -0.03 | -0.25 |
| EBITDA(a) | $-22,792 | $-24,626 | $-20,079 | $-18,341 | $-21,019 |